Ashraf H Ahmed Selected Research

Hyperaldosteronism (Conn Syndrome)

1/2020	Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism.
1/2020	Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability Between Immunoassay and HPLC-MS/MS.
11/2018	Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
11/2018	Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism.
1/2017	Effect of Moxonidine on the Aldosterone/Renin Ratio in Healthy Male Volunteers.
1/2017	Effect of Combined Hormonal Replacement Therapy on the Aldosterone/Renin Ratio in Postmenopausal Women.
11/2016	Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism?
10/2015	Does concomitant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism?
9/2015	Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study.
4/2015	Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashraf H Ahmed Research Topics

Disease

18	Hyperaldosteronism (Conn Syndrome) 01/2020 - 07/2010
4	Hypertension (High Blood Pressure) 01/2017 - 10/2013
2	Adenoma (Adenomas) 10/2015 - 10/2013
1	Renal Artery Obstruction (Renal Artery Stenosis) 09/2015
1	Fibrosis (Cirrhosis) 09/2011
1	Hypertrophy 09/2011
1	Essential Hypertension 02/2011

Drug/Important Bio-Agent (IBA)

16	AldosteroneIBA 01/2020 - 07/2010
9	ReninIBA 01/2020 - 07/2010
4	FludrocortisoneIBA 01/2020 - 08/2014
3	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2015 - 10/2013
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 04/2015
2	SaltsIBA 01/2020 - 09/2011
1	Angiotensin IIIBA 01/2020
1	moxonidine (Moxon)IBA 01/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2016
1	Dichlorodiphenyldichloroethane (DDD)IBA 09/2015
1	SodiumIBA 08/2014
1	Spironolactone (Aldactone)FDA LinkGeneric 09/2011
1	Amiloride (Midamor)FDA LinkGeneric 09/2011
1	Dietary SodiumIBA 09/2011
1	drospirenone FDA LinkGeneric 06/2011
1	Combined Oral ContraceptivesIBA 06/2011

Therapy/Procedure

4	Adrenalectomy 10/2015 - 09/2011